You are viewing: Canada Humanized Mouse and Rat Model Market analysis

The Canada Humanized Mouse and Rat Model Market was valued at $24 Million in 2025 and projected to reach to $34.8 Million by 2030, representing a compound annual growth rate of CAGR 7.7%. Canada's humanized mouse and rat model market is experiencing robust growth, fueled by substantial investments in biotechnology infrastructure and a growing emphasis on preclinical research excellence.

Canada Humanized Mouse and Rat Model Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Humanized Mouse and Rat Model Market Trends and Insights

  • This growth trajectory reflects Canada's strengthening position in preclinical research and drug development, driven by increased investment in biotechnology infrastructure and rising demand for advanced animal models in pharmaceutical testing.
  • Canada's research institutions and contract research organizations are increasingly adopting humanized mouse and rat models to accelerate translational medicine initiatives and improve drug efficacy assessments. The Canadian market benefits from robust government funding for life sciences research, a skilled workforce in biomedical sciences, and strategic partnerships between academic centers and pharmaceutical companies.
  • Canada's commitment to reducing animal testing through more predictive models has positioned humanized rodents as critical tools in the country's drug development pipeline.
  • Between 2025 and 2030, Canada is expected to see heightened adoption across oncology, immunology, and infectious disease research sectors, supported by regulatory frameworks that encourage innovation in preclinical methodologies..

Key Market Statistics

  • CAGR (2025-2030) CAGR 7.7%
  • Market Size, 2025 ~USD 24 Million
  • Forecast, 2030 ~USD 34.8 Million
  • Country Canada

Canada Humanized Mouse and Rat Model Market Overview

Market Valuation :

Canada's humanized mouse and rat model market is valued at $24.0 million in 2025, with strong growth momentum driven by expanding biotechnology research initiatives across the country.

Growth Trajectory :

The market is projected to reach $34.8 million by 2030, representing a 7.7% CAGR, outpacing many developed markets due to increased government funding and private sector investment in preclinical research.

Biotechnology Infrastructure :

Canada's strengthening position in preclinical research is supported by world-class research institutions, government grants, and collaborative partnerships between academic centers and pharmaceutical companies.

Drug Development Demand :

Rising demand for advanced animal models in Canada reflects the country's commitment to accelerating drug discovery pipelines and reducing time-to-market for innovative therapeutics.

Canada Humanized Mouse and Rat Model Market Dynamics

  • The country's research institutions and pharmaceutical companies are increasingly adopting advanced animal models to streamline drug development processes and improve efficacy testing.
  • Government support through funding initiatives and tax incentives is further accelerating market expansion.
  • By 2030, the market is expected to reach $34.8 million, driven by rising demand for personalized medicine research and the need for more predictive preclinical models.
  • Canada's strategic position in North American drug development, combined with its regulatory framework and skilled workforce, positions it as a key hub for humanized model research and development..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Canada's humanized mouse and rat model market is valued at $24.0 million in 2025 and will reach $34.8 million by 2030 at a 7.7% CAGR.
    • Canada's strong biotech ecosystem and government R&D funding are primary drivers of market expansion in preclinical research.
    • Canadian pharmaceutical and biotech companies are increasingly leveraging humanized models to accelerate drug development timelines and reduce animal testing.
    • Canada's regulatory environment and academic-industry partnerships position the country as a growing hub for advanced preclinical research methodologies.

    Humanized Mouse and Rat Model Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS AND CDMOS) (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.2% from 2025 to 2030
    Largest Segment HUMANIZED MOUSE MODELS (Type)
    Market Size Base Year (Billions) ~USD 0.28 (2025)
    Revenue Forecast (Billions) ~USD 0.41 (2030)
    Segments Covered Type, End User, Application

    Canada Humanized Mouse and Rat Model Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Type

    • Blt Humanized Mouse Models
    • Cd34 Humanized Mouse Models
    • Cell-Based Humanized Mouse Models
    • Genetic Humanized Mouse Models
    • Humanized Mouse Models
    • Humanized Rat Models
    • Pbmc Humanized Mouse Models

    By End User

    • Academic & Research Institutes
    • Academic And Research Institutes
    • Contract Research Organizations And Contract Development And Manufacturing Organizations (Cros And Cdmos)
    • Cros & Cdmos
    • Cros And Cdmos
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical And Biotechnology Companies

    By Application

    • Hematopoiesis
    • Immunology And Infectious Diseases
    • Neuroscience
    • Oncology
    • Other Applications
    • Toxicology

    CANADA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES3.43.43.63.84.14.34.54.75.3
    CROS AND CDMOS5.766.57.27.88.59.310.19.2
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES12.51313.915.116.217.418.7207.5
    TOTAL21.522.42426.128.130.232.434.87.7

    Target Audience

    • Pharmaceutical Companies : Canadian and international pharma firms need market data to assess preclinical research opportunities, plan R&D investments, and identify partnerships with Canadian research institutions.
    • Biotechnology Firms : Biotech companies require Canada-specific market intelligence to evaluate market entry strategies, competitive positioning, and growth potential in the humanized model segment.
    • Research Institutions : Universities and research centers need market insights to justify funding requests, demonstrate market relevance, and identify collaboration opportunities with industry partners.
    • Investors & Venture Capitalists : Investment firms require detailed Canadian market analysis to identify promising biotech startups, assess market growth potential, and make informed funding decisions in preclinical research.
    • Government & Policy Makers : Canadian government agencies and policy bodies need market data to inform biotechnology strategy, allocate research funding, and support the country's competitive position in life sciences.

    Key Companies in the Canada Humanized Mouse and Rat Model Market

    CompanyHQOwnershipStrongest segments
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    THE JACKSON LABORATORYUnited StatesFoundation/Charitable InstitutionMouse breeding and colony management,Phenotyping, efficacy testing, and genetic research services,Genetic resources, software, and data,
    INOTIVUnited StatesPublic CompanyResearch Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
    GENOWAYFrancePublic CompanyCustom mouse models (KO/KI and humanized),Custom rat models,Engineered cell lines,
    JSR CORPORATIONJapanPrivate CompanyDigital Solutions (lithography, photoresists, CMP, display and packaging materials),Plastics / Synthetic Resins (ABS, AES, AS, ASA and related resins),Life Sciences (diagnostic and research reagents, bioprocess materials, drug discovery support),
    CHAMPIONS ONCOLOGY, INC.United StatesPublic CompanyTumorgraft / PDX-based translational oncology services,Personalized cancer care services,Lumin Bioinformatics and data-driven software,
    ONCODESIGN SERVICESFrancePublic CompanyPrecision oncology and immuno-oncology (OPM-101, OPM-102),Neurodegeneration (OPM-201, Parkinson’s),Radiotheranostic portfolio for digestive and pancreatic cancers,

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a public company founded in 1947 in the United States with 19,000 employees.

    THE JACKSON LABORATORY

    The Jackson Laboratory is a foundation-based charitable institution founded in 1929 in the United States with 2,100 employees.

    INOTIV

    Inotiv is a public company founded in 1974 in the United States with 1,996 employees.

    GENOWAY

    Genoway is a public company founded in 1999 in France with 157 employees.

    JSR CORPORATION

    JSR Corporation is a private company founded in 1948 in Japan with 7,997 employees.

    CHAMPIONS ONCOLOGY, INC.

    Champions Oncology, Inc. is a public company founded in 1985 in the United States with 214 employees.

    ONCODESIGN SERVICES

    Oncodesign Services is a public company founded in 1995 in France.

    Reasons to Buy this Report

    • Market-Specific Sizing : Access precise valuation data for Canada's humanized model market with detailed 2025-2030 forecasts, enabling accurate budget allocation and investment planning specific to the Canadian market.
    • Competitive Landscape Intelligence : Understand Canada's unique market dynamics, key players, and regional growth drivers that differentiate it from global trends, supporting strategic positioning in this emerging market.
    • Investment Decision Support : Leverage Canada-specific growth projections and CAGR analysis to identify expansion opportunities, partnerships, and funding requirements for biotechnology ventures in the country.
    • Regulatory & Infrastructure Insights : Gain insights into Canada's research infrastructure, government support programs, and regulatory environment that impact humanized model adoption and market development.
    • Stakeholder Alignment : Present data-driven evidence to investors, boards, and partners about Canada's market potential, supporting business cases for R&D investments and facility expansion decisions.

    Frequently asked questions

    What is the current market size of humanized mouse and rat models in Canada?

    Canada's humanized mouse and rat model market is valued at $24.0 million in 2025, with expectations to grow to $34.8 million by 2030.

    What is the projected growth rate for Canada's humanized mouse and rat model market?

    Canada's market is expected to grow at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.

    Which sectors in Canada are driving demand for humanized mouse and rat models?

    Canada's oncology, immunology, and infectious disease research sectors are primary drivers of demand for humanized rodent models in preclinical drug development.

    Why are Canadian research institutions adopting humanized mouse and rat models?

    Canadian institutions are adopting these models to accelerate translational medicine, improve drug efficacy assessments, and align with regulatory frameworks that encourage alternatives to traditional animal testing.

    What factors support market growth in Canada?

    Canada's market growth is supported by robust government R&D funding, a skilled biomedical workforce, strategic academic-industry partnerships, and regulatory incentives for advanced preclinical methodologies.

    RESEARCH METHODOLOGY

    The research study used secondary sources, directories, and databases to identify and collect valuable information to analyze the global humanized mouse and rat model market. Widespread interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size was estimated through secondary research (top-down and bottom-up), followed by data triangulation with inputs from industry experts to determine the final market size.

    Secondary Research

    Secondary research was used to identify and collect information for the technical, market-oriented, and commercial study of the humanized mouse and rat model market. The secondary sources used for this study include the American Association for Cancer Research (AACR), American Association for Laboratory Animal Science (AALAS), European Society for Medical Oncology (ESMO), European Association for Cancer Research (EACR), Humanized Mouse Resource (HMR), National Center for Biotechnology Information (NCBI), and Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).

    Academic Journals and Company Websites; corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations were also used to obtain major information about key market players and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analyzed to determine the market size of the global humanized mouse and rat model market, which was further validated through primary research.

    Primary Research

    Primary research was conducted after acquiring basic knowledge about the global humanized mouse and rat model market through secondary research. A series of primary interviews were conducted with market experts from the demand side, including professionals from the pharmaceutical and biopharmaceutical industries and academic institutions. Additionally, interviews were held with individuals from the supply side, such as C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners. The primary interviews were conducted across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants. This data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The breakdown of the primary respondents is given below.

    Humanized Mouse and Rat Model Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Top-down and bottom-up approaches were used to estimate and validate the total size of the humanized mouse and rat model market. These methods were also used extensively to estimate the size of various subsegments in the market.

    Humanized Mouse and Rat Model Market

    Data Triangulation

    After determining the market size from the above estimation process, the total market was divided into several segments and subsegments. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides.

    Market Definition

    A humanized mouse and rat model is an immunodeficient organism genetically engineered to study immune responses to drugs or identify potential disease targets. These models are widely used to study human diseases and genes. Researchers in both academia and industry, along with clinicians, extensively use humanized mouse and rat models in their research applications. Humanized mouse and rat models are beneficial tools for immuno-oncology and infectious disease research. They have improved the ability to predict human responses to new therapeutics in clinical development.

    Stakeholders

    • Research and consulting firms
    • Biopharmaceutical manufacturers
    • Pharmaceutical manufacturers
    • Mouse model and service companies
    • Government and private research institutes
    • Manufacturers and suppliers of animal care products
    • Clinical research organizations (CROs)
    • Academic and research institutes
    • Venture capitalists
    • Laboratory animal care associations
    • Public and private animal health agencies

    Report Objectives

     

    To define, describe, and forecast the humanized mouse and rat model market by type, application, end user, and region

    To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)

    • To analyze the micromarkets1 concerning individual growth trends, prospects, and contributions to the overall humanized mouse and rat model market
    • To assess the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments for North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
    • To profile the key players and analyze their market shares and core competencies2
    • To track and analyze competitive developments, such as product/service launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

     

    Get the Full Humanized Mouse and Rat Model Market Report

    Full forecast, segment splits, and company analysis for all Humanized Mouse and Rat Model Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status